BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Valiente M, Van Swearingen AED, Anders CK, Bairoch A, Boire A, Bos PD, Cittelly DM, Erez N, Ferraro GB, Fukumura D, Gril B, Herlyn M, Holmen SL, Jain RK, Joyce JA, Lorger M, Massague J, Neman J, Sibson NR, Steeg PS, Thorsen F, Young LS, Varešlija D, Vultur A, Weis-Garcia F, Winkler F. Brain Metastasis Cell Lines Panel: A Public Resource of Organotropic Cell Lines. Cancer Res 2020;80:4314-23. [PMID: 32641416 DOI: 10.1158/0008-5472.CAN-20-0291] [Cited by in Crossref: 14] [Cited by in F6Publishing: 9] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 Klemm F, Möckl A, Salamero-Boix A, Alekseeva T, Schäffer A, Schulz M, Niesel K, Maas RR, Groth M, Elie BT, Bowman RL, Hegi ME, Daniel RT, Zeiner PS, Zinke J, Harter PN, Plate KH, Joyce JA, Sevenich L. Compensatory CSF2-driven macrophage activation promotes adaptive resistance to CSF1R inhibition in breast-to-brain metastasis. Nat Cancer 2021;2:1086-101. [PMID: 35121879 DOI: 10.1038/s43018-021-00254-0] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
2 Kros JM, Mustafa DAM. Cerebral Metastasis of Common Cancers. Cancers (Basel) 2020;13:E65. [PMID: 33383615 DOI: 10.3390/cancers13010065] [Reference Citation Analysis]
3 Darrigues E, Elberson BW, De Loose A, Lee MP, Green E, Benton AM, Sink LG, Scott H, Gokden M, Day JD, Rodriguez A. Brain Tumor Biobank Development for Precision Medicine: Role of the Neurosurgeon. Front Oncol 2021;11:662260. [PMID: 33981610 DOI: 10.3389/fonc.2021.662260] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Jablonska PA, Bosch-Barrera J, Serrano D, Valiente M, Calvo A, Aristu J. Challenges and Novel Opportunities of Radiation Therapy for Brain Metastases in Non-Small Cell Lung Cancer. Cancers (Basel) 2021;13:2141. [PMID: 33946751 DOI: 10.3390/cancers13092141] [Reference Citation Analysis]
5 Caulfield JI, Kluger HM. Emerging Studies of Melanoma Brain Metastasis. Curr Oncol Rep 2022. [PMID: 35212922 DOI: 10.1007/s11912-022-01237-9] [Reference Citation Analysis]
6 Rehman AU, Khan P, Maurya SK, Siddiqui JA, Santamaria-Barria JA, Batra SK, Nasser MW. Liquid biopsies to occult brain metastasis. Mol Cancer 2022;21:113. [PMID: 35538484 DOI: 10.1186/s12943-022-01577-x] [Reference Citation Analysis]
7 Singh M, Dahal A, Brastianos PK. Preclinical Solid Tumor Models to Study Novel Therapeutics in Brain Metastases. Curr Protoc 2021;1:e284. [PMID: 34762346 DOI: 10.1002/cpz1.284] [Reference Citation Analysis]
8 Kovalchuk B, Berghoff AS, Karreman MA, Frey K, Piechutta M, Fischer M, Grosch J, Heiland S, Breckwoldt MO, Hilberg F, Wick W, Winkler F. Nintedanib and a bi-specific anti-VEGF/Ang2 nanobody selectively prevent brain metastases of lung adenocarcinoma cells. Clin Exp Metastasis 2020;37:637-48. [PMID: 32918638 DOI: 10.1007/s10585-020-10055-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
9 Cosgrove N, Varešlija D, Keelan S, Elangovan A, Atkinson JM, Cocchiglia S, Bane FT, Singh V, Furney S, Hu C, Carter JM, Hart SN, Yadav S, Goetz MP, Hill ADK, Oesterreich S, Lee AV, Couch FJ, Young LS. Mapping molecular subtype specific alterations in breast cancer brain metastases identifies clinically relevant vulnerabilities. Nat Commun 2022;13:514. [PMID: 35082299 DOI: 10.1038/s41467-022-27987-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
10 Busatto S, Morad G, Guo P, Moses MA. The role of extracellular vesicles in the physiological and pathological regulation of the blood-brain barrier. FASEB Bioadv 2021;3:665-75. [PMID: 34485835 DOI: 10.1096/fba.2021-00045] [Reference Citation Analysis]
11 Steeg PS. The blood-tumour barrier in cancer biology and therapy. Nat Rev Clin Oncol 2021. [PMID: 34253912 DOI: 10.1038/s41571-021-00529-6] [Reference Citation Analysis]
12 Masmudi-Martín M, Zhu L, Sanchez-Navarro M, Priego N, Casanova-Acebes M, Ruiz-Rodado V, Giralt E, Valiente M. Brain metastasis models: What should we aim to achieve better treatments? Adv Drug Deliv Rev 2021;169:79-99. [PMID: 33321154 DOI: 10.1016/j.addr.2020.12.002] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 7.0] [Reference Citation Analysis]
13 Zimmer AS. "Triple-Negative Breast Cancer Central Nervous System Metastases From the Laboratory to the Clinic". Cancer J 2021;27:76-82. [PMID: 33475296 DOI: 10.1097/PPO.0000000000000503] [Reference Citation Analysis]
14 Nakayama J, Han Y, Kuroiwa Y, Azuma K, Yamamoto Y, Semba K. The In Vivo Selection Method in Breast Cancer Metastasis. Int J Mol Sci 2021;22:1886. [PMID: 33672831 DOI: 10.3390/ijms22041886] [Reference Citation Analysis]
15 Andersen BM, Faust Akl C, Wheeler MA, Chiocca EA, Reardon DA, Quintana FJ. Glial and myeloid heterogeneity in the brain tumour microenvironment. Nat Rev Cancer 2021. [PMID: 34584243 DOI: 10.1038/s41568-021-00397-3] [Reference Citation Analysis]
16 Miarka L, Valiente M. Animal models of brain metastasis. Neurooncol Adv 2021;3:v144-56. [PMID: 34859241 DOI: 10.1093/noajnl/vdab115] [Reference Citation Analysis]
17 Zhu L, Retana D, García-Gómez P, Álvaro-Espinosa L, Priego N, Masmudi-Martín M, Yebra N, Miarka L, Hernández-Encinas E, Blanco-Aparicio C, Martínez S, Sobrino C, Ajenjo N, Artiga MJ, Ortega-Paino E, Torres-Ruiz R, Rodríguez-Perales S, Soffietti R, Bertero L, Cassoni P, Weiss T, Muñoz J, Sepúlveda JM, González-León P, Jiménez-Roldán L, Moreno LM, Esteban O, Pérez-Núñez Á, Hernández-Laín A, Toldos O, Ruano Y, Alcázar L, Blasco G, Fernández-Alén J, Caleiras E, Lafarga M, Megías D, Graña-Castro O, Nör C, Taylor MD, Young LS, Varešlija D, Cosgrove N, Couch FJ, Cussó L, Desco M, Mouron S, Quintela-Fandino M, Weller M, Pastor J, Valiente M; RENACER. A clinically compatible drug-screening platform based on organotypic cultures identifies vulnerabilities to prevent and treat brain metastasis. EMBO Mol Med 2022;:e14552. [PMID: 35174975 DOI: 10.15252/emmm.202114552] [Reference Citation Analysis]